Victory Capital Management’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-386,666
| Closed | -$677K | – | 2542 |
|
|
2025
Q1 | $677K | Sell |
386,666
-3,220
| -0.8% | -$5.64K | ﹤0.01% | 1949 |
|
|
2024
Q4 | $616K | Sell |
389,886
-8,980
| -2% | -$14.2K | ﹤0.01% | 1974 |
|
|
2024
Q3 | $626K | Buy |
398,866
+37,480
| +10% | +$58.8K | ﹤0.01% | 1950 |
|
|
2024
Q2 | $645K | Sell |
361,386
-6,760
| -2% | -$12.1K | ﹤0.01% | 1897 |
|
|
2024
Q1 | $1.06M | Buy |
368,146
+96,410
| +35% | +$278K | ﹤0.01% | 1713 |
|
|
2023
Q4 | $348K | Buy |
271,736
+38,529
| +17% | +$49.3K | ﹤0.01% | 2087 |
|
|
2023
Q3 | $322K | Buy |
233,207
+11,701
| +5% | +$16.1K | ﹤0.01% | 2103 |
|
|
2023
Q2 | $326K | Hold |
221,506
| – | – | ﹤0.01% | 2096 |
|
|
2023
Q1 | $188K | Hold |
221,506
| – | – | ﹤0.01% | 2257 |
|
|
2022
Q4 | $303K | Hold |
221,506
| – | – | ﹤0.01% | 2170 |
|
|
2022
Q3 | $377K | Hold |
221,506
| – | – | ﹤0.01% | 2169 |
|
|
2022
Q2 | $459K | Sell |
221,506
-1,797
| -0.8% | -$3.72K | ﹤0.01% | 2091 |
|
|
2022
Q1 | $664K | Sell |
223,303
-51
| -0% | -$152 | ﹤0.01% | 2009 |
|
|
2021
Q4 | $704K | Buy |
223,354
+633
| +0.3% | +$2K | ﹤0.01% | 1987 |
|
|
2021
Q3 | $1.54M | Sell |
222,721
-1,073
| -0.5% | -$7.41K | ﹤0.01% | 1680 |
|
|
2021
Q2 | $1.82M | Buy |
223,794
+1,074
| +0.5% | +$8.73K | ﹤0.01% | 1657 |
|
|
2021
Q1 | $3.47M | Buy |
222,720
+172,721
| +345% | +$2.69M | ﹤0.01% | 1470 |
|
|
2020
Q4 | $675K | Buy |
+49,999
| New | +$675K | ﹤0.01% | 1929 |
|
|
2020
Q2 | – | Sell |
-583
| Closed | -$2K | – | 3122 |
|
|
2020
Q1 | $2K | Buy |
+583
| New | +$2K | ﹤0.01% | 3667 |
|
|
2019
Q4 | – | Sell |
-299
| Closed | -$2K | – | 3144 |
|
|
2019
Q3 | $2K | Buy |
+299
| New | +$2K | ﹤0.01% | 3640 |
|
|
2018
Q1 | – | Sell |
-2,731
| Closed | -$341K | – | 1898 |
|
|
2017
Q4 | $341K | Buy |
2,731
+421
| +18% | +$52.6K | ﹤0.01% | 1355 |
|
|
2017
Q3 | $347K | Buy |
+2,310
| New | +$347K | ﹤0.01% | 1357 |
|